FIELD: medicine.
SUBSTANCE: invention concerns medicine, namely to haematology, and is referred to the method of stimulation of myelopoiesis. For this purpose administer Hyaluronidasum in effective dose specially developed for it.
EFFECT: provision of wide spectrum of haemostimulating action on hemopoietic tissue, rendering thus the minimum medicinal load on an organism.
2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF MYELOPOIESIS STIMULATION | 2008 |
|
RU2366452C1 |
| METHOD FOR STIMULATING MYELOGENESIS | 2010 |
|
RU2442589C1 |
| METHOD OF DETERMINING EFFICACY OF HAEMOSTIMULATORS IN CYTOSTATIC MYELOSUPPRESSION | 2009 |
|
RU2421720C2 |
| HEMOSTIMULANT AND EXCITANT AND METHOD FOR HEMOPOIESIS STIMULATION | 2009 |
|
RU2414926C1 |
| METHOD FOR SIMULATING CHRONIC CYTOSTATIC MYELOSUPPRESSION | 2012 |
|
RU2488890C1 |
| AGENT INTENSIFYING ACTION OF BIOLOGICALLY ACTIVE SUBSTANCES AND DRUGS | 2009 |
|
RU2421239C1 |
| METHOD OF GRANULOCYTOPOIESIS DEPRESSION CORRECTION IN CYTOSTATIC ACTION | 2008 |
|
RU2366422C1 |
| METHOD FOR PREPARING CELL TRANSPLANTATION MATERIAL IN MYELOSUPPRESSION | 2008 |
|
RU2392947C1 |
| PREPARATION PREVENTING DEVELOPMENT OF DEPRESSION OF ERITHROID HEMATOPOIESIS SHOOT WITH INTRODUCTION OF CYTOSTATIC | 2007 |
|
RU2354376C1 |
| METHOD OF GRANULOCYTOPENIA-STIMULATING EFFECT EVALUATION FOR PHARMACOLOGICAL SUBSTANCES | 2006 |
|
RU2332667C1 |
